Clinical practice guidelines on progression and advanced glaucoma

Pablo, L.E.

doi:10.1016/j.oftale.2022.09.004

array:22 ["pii" => "S2173579422001761" "issn" => "21735794" "doi" => "10.1016/j.oftale.2022.09.004" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "2056" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Arch Soc Esp Oftalmol. 2023;98:1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:18 [ "pii" => "S0365669122002143" "issn" => "03656691" "doi" => "10.1016/j.oftal.2022.09.003" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "2056" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Arch Soc Esp Oftalmol. 2023;98:1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "Editorial" "titulo" => "Guías de práctica clínica en progresión y glaucoma avanzado" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "1" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Clinical practice guidelines on progression and advanced glaucoma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "L.E. Pablo" "autores" => array:1 [ 0 => array:2 [ "nombre" => "L.E." "apellidos" => "Pablo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173579422001761" "doi" => "10.1016/j.oftale.2022.09.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173579422001761?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365669122002143?idApp=UINPBA00004N" "url" => "/03656691/0000009800000001/v1_202301030725/S0365669122002143/v1_202301030725/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173579422001748" "issn" => "21735794" "doi" => "10.1016/j.oftale.2022.11.002" "estado" => "S300" "fechaPublicacion" => "2023-01-01" "aid" => "2057" "copyright" => "Sociedad Española de Oftalmología" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Arch Soc Esp Oftalmol. 2023;98:2-10" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "Original article" "titulo" => "Budget impact analysis of the XEN®63 for the treatment of primary openangle glaucoma in Spain" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "2" "paginaFinal" => "10" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Impacto presupuestario de XEN®63 en el tratamiento del glaucoma primario de ángulo abierto en España" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2338 "Ancho" => 3250 "Tamanyo" => 390330 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0055" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "Candidate target population for XEN®63. POAG: primary open-angle glaucoma Source: 1. INE<a class="elsevierStyleCrossRef" href="#bib0115">23</a>; 2. Antón et al.<a class="elsevierStyleCrossRef" href="#bib0005">1</a>; 3. EGS<a class="elsevierStyleCrossRef" href="#bib0010">2</a>; 4. Stein et al.<a class="elsevierStyleCrossRef" href="#bib0120">24</a>; 5. Lorenz et al.<a class="elsevierStyleCrossRef" href="#bib0125">25</a>; 6. Allergan. Internal data.<a class="elsevierStyleCrossRef" href="#bib0130">26</a>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "J. Vila Arteaga, E. Gutierrez Díaz, J.M. Martínez de la Casa, E. Millá Griñó, A. Asorey García, J. Salvador Alepuz, C. de Miguel González, R. Palomino Meneses, E. Uría Mundo" "autores" => array:9 [ 0 => array:2 [ "nombre" => "J." "apellidos" => "Vila Arteaga" ] 1 => array:2 [ "nombre" => "E." "apellidos" => "Gutierrez Díaz" ] 2 => array:2 [ "nombre" => "J.M." "apellidos" => "Martínez de la Casa" ] 3 => array:2 [ "nombre" => "E." "apellidos" => "Millá Griñó" ] 4 => array:2 [ "nombre" => "A." "apellidos" => "Asorey García" ] 5 => array:2 [ "nombre" => "J." "apellidos" => "Salvador Alepuz" ] 6 => array:2 [ "nombre" => "C." "apellidos" => "de Miguel González" ] 7 => array:2 [ "nombre" => "R." "apellidos" => "Palomino Meneses" ] 8 => array:2 [ "nombre" => "E." "apellidos" => "Uría Mundo" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0365669122002313" "doi" => "10.1016/j.oftal.2022.09.004" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365669122002313?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173579422001748?idApp=UINPBA00004N" "url" => "/21735794/0000009800000001/v1_202301060758/S2173579422001748/v1_202301060758/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "Editorial" "titulo" => "Clinical practice guidelines on progression and advanced glaucoma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "1" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "L.E. Pablo" "autores" => array:1 [ 0 => array:4 [ "nombre" => "L.E." "apellidos" => "Pablo" "email" => array:1 [ 0 => "lpablo@unizar.es" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Oftalmología, Hospital Universitario Miguel Servet, Zaragoza, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Guías de práctica clínica en progresión y glaucoma avanzado" ] ] "textoCompleto" => "The practice of clinical medicine has an obvious scientific component that must be combined with the "art" of implementing the knowledge of professionals in the real world. When faced with a given patient or clinical situation, experience, an individual point of view and the wealth of knowledge and resources currently available to us enable the development of the most appropriate solution for the treatment and management of our patients.Glaucoma is still a complex syndrome in which many factors are involved, depending on the disease itself, the patient and even the patient's environment and circumstances. The new diagnostic and therapeutic means available to the clinician allow for a personalised and individual approach in the monitoring of the process. For this reason, the help of the experience and knowledge of other professionals is a fundamental instrument for the clinical management of our patients.A Clinical Practice Guideline (CPG) is nothing more than an orderly and well-considered set of recommendations based on evidence and which represent a kind of signposting of the path to follow and of the various options available. Hence, CPGs are necessary to organise and evaluate the available knowledge and reduce variability in our practice.The management of advanced glaucoma continues to be a challenge for the clinician, the ground effect of OCT, the difficulty of conventional campimetry to detect small changes with great clinical significance or the role of new tools such as OCT-A are peculiarities addressed in the text. The guide sheds light on questions such as where to place the target pressure or the most appropriate surgical treatment in each case.In some cases, the progression of glaucoma is evident and a visual field analysis, OCT or the appearance of the cup itself is enough proof. In other cases it is not so simple: atypical papillae, myopia, concomitant pathologies, ageing, the subtlety of change or technological failures invalidate an otherwise simple assessment.This progression guide includes the different options that define functional and structural progression and the expected progression rates among our patients. New trends in progression assessment are based on structural-functional relationships and the role of artificial intelligence, which is gradually becoming a genuine and consolidated option in daily medical practice.Scientific societies favour the flow of knowledge and opinions between professionals from different places and schools, who establish professional and often personal links. Research networks have allowed these relationships to become even closer and a healthy exchange of people and ideas between different groups. Said iterations have given rise to very useful initiatives such as these guidelines, which are undoubtedly a reference tool for the present and future practice of glaucomatologists and ophthalmologists in our country." "pdfFichero" => "main.pdf" "tienePdf" => true ] "idiomaDefecto" => "en" "url" => "/21735794/0000009800000001/v1_202301060758/S2173579422001761/v1_202301060758/en/main.assets" "Apartado" => array:4 [ "identificador" => "5814" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735794/0000009800000001/v1_202301060758/S2173579422001761/v1_202301060758/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173579422001761?idApp=UINPBA00004N"]

ISSN: 2173-5794
e-ISSN: 1989-7286

Archivos de la Sociedad Española de Oftalmología is the official journal of the Ophthalmology Society of Spain, that has over 4,000 members. It gives priority to the publication of basic, translational and clinic research including reviews, original articles, short communications, editorials, letters to the editor and clinic practice guides related to Ophthalmology and its subspecialties. A small section of the journal is reserved for the most relevant papers presented at the annual Congress of the Society. All manuscripts considered for publication are reviewed by expert examiner peers (double blind). The journal is published monthly and even though its official language is Spanish all articles are translated into English to increase the dissemination of scientific information. At present, Archivos is the only Spanish language Ophthalmology journal indexed in PubMed/MEDLINE in addition to other prestigious international databases such as Scopus.

See more Open Access Option

Indexed in:

PubMed/MedLine, Scopus, EMBASE, IBECS, IME, SCIELO, BIOSIS, SENIOR, COMPLUDOC

Subscribe:

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

1.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.247

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.263

View more metrics

Journal Information

Previous article | Next article

Vol. 98. Issue 1.